Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02040987 · ClinicalTrials.gov registry record · Phase 1
AZD3293 Thorough QT Study in Healthy Male Volunteers
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 52
- Enrollment target
NCT02040987 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 52 participants.
The verdict
NCT02040987, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 52 participants
- Enrollment target
Study Summary
A thorough QT study of AZD3293
Interventions
- DRUG Placebo
- DRUG Moxifloxacin
- DRUG AZD3293
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02040987
The ClinicalTrials.gov registry entry for NCT02040987 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02040987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02040987 about?
NCT02040987 is a clinical study titled "AZD3293 Thorough QT Study in Healthy Male Volunteers". A thorough QT study of AZD3293
What is the current status of trial NCT02040987?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2014-01. Estimated completion is 2014-05.
What interventions are being tested in trial NCT02040987?
The interventions under investigation include: Placebo (DRUG), Moxifloxacin (DRUG), AZD3293 (DRUG).
Who is sponsoring clinical trial NCT02040987?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.